New antibiotics tested in Real-World study for tough infections
NCT ID NCT06990126
First seen Jan 06, 2026 · Last updated May 23, 2026 · Updated 19 times
Summary
This study is looking at how effective and safe neotetracycline drugs (like eravacycline and tigecycline) are for treating gram-negative bacterial infections. Researchers will review medical records of about 400 adults who have drug-resistant infections and have taken these antibiotics for at least 3 days. The goal is to see if symptoms improve and if there are any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL EFFICACY AND SAFETY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Conditions
Explore the condition pages connected to this study.